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The presence of IgA antibody to membrane antigen (MA) of Epstein-Barr virus (EBV) was tested in sera from 48 nasopharyngeal carcinoma (NPC) patients. 40 patients with tumors other than NPC and 46 normal individuals.
The sera were preabsorbed with Staphylococcus aureus (SPA) (strain no. 1800) prior to their use in the indirect immunofluorescence test. One hundred percent of the NPC patients had the IgAiMA antibody with a GMT of 1:141. In patients with tumors other than NPC or normal individuals, IgAiMA antibodies were not detectable.
The IgAiMA antibodies have been demonstrated in 6 NPC patients lacking detectable antibody levels in the indirect immunofluorescence test using nonabsorbed sera. Our data indicate that preabsorbtion of sera with SPA renders the diagnostic test significantly more sensitive for the detection of the nasopharyngeal carcinoma and can be used for trials on the prognosis of patients. Klein et al. (1966) (Klein et al., 1969) . The antibodies to EBV-MA in sera from nasopharyngeal carcinoma (NPC) patients were tested (De Schryver et al., 1969; Zhu et al., 1986) . For the IgA/MA antibody, 58.3% of NPC patients were positive with a GMT of 1:7.3 and none of the normal individuals were positive.
Introduction
The detection of IgA/MA antibodies appeared to be specific for NPC, but not as sensitive as the detection of IgA/EA which allowed detection rates of up to 70% (Zeng et al., 1983a) . It is therefore necessary to improve the sensitivity of this test for the detection of the IgAiMA antibody.
Here we report on a new technique and its application for detection of the IgAiMA antibody in NPC patients.
Materials and Methods

Seru
Sera were taken from 48 NPC patients, 40 patients with tumors other than NPC and 46 normal individuals.
and stored at -20°C.
Procedure
The target cells used for detection of the IgAiMA antibody were B95-8 cells, activated for 24 h by iz-butyrate (4 mM) and croton oil (500 ngiml). The activated cells were washed 3 times with Hank's solution and adjusted to 2 X lo6 cells/ml. 110" cells in 50 ~1 were added to each well of 96 well U-shaped hemagglutination plates.
Serum samples were treated prior to titration in the following manner: 25 ml of each serum was diluted 1:5 by adding 25 r*_l ~tap~yIoc~ccr~s aweus (SPA) (10% suspension of formalin inactivated bacteria; Kessler, 1975) and 7.5 l_~l Hank's solution. The mixtures were incubated at 37°C for 1 h and then centrifuged at 3000 rpm for 20 min. The supernate was considered 1:5 diluted and was further diluted from 1:lO to 1:1280 in 2-fold dilution steps. SO ~1 of each dilution of serum were added to each well with target cells. The plates were incubated in a humid chamber at 37°C for 45 min. After washing 3 times with Hank's solution, the incubated cells were smeared on special Teflon-coated slides with clear areas, air dried and fixed with cold acetone.
1:lO diluted sheep anti-human IgA antibody conjugated with FITC was added and the slides were kept at 37°C for 45 min. The cell smears were again washed 3 times with 0.01 M PBS (pH 7.6). After counter-staining with 0.006% Evans blue for 10 min, they were examined under an Olympus fluorescence microscope.
The cell membrane stained with specific green color was considered to be positive.
Immunoenzymatic test
The test was done as described by Zeng et al. (1979) . ies with the immunoenzymatic test and for IgA/MA antibodies with IF using sera untreated or preabsorbed with SPA, respectively. The results are given in Table 1 .
Results
Comparison
Specificity and sensitivity of the modified method
Previous studies (Zhu et al., 1986) have detected IgAiMA antibodies in only 58.3% of NPC cases. In order to test whether competing IgG antibodies in the remaining 41.7% of sera were responsible for the negative results for IgA/MA antibodies, sera from 12 NPC patients and 10 normal individuals were tested in parallel using nonabsorbed and SPA-preabsorbed sera, respectively. As seen in Table 2 , the GMT of the IgA/MA antibody titers were 8 times higher in preabsorbed sera. Antibody titers of 1: 160 and higher were found in 50% of the preabsorbed sera group but only in one of the 12 nonabsorbed sera. There is no positive result in preabsorbed sera from normal individuals. A good correlation between antibody titers detected by the modified method and the immunoenzymatic test was obtained (Fig. 1) . In most NPC cases, the antibody titers for IgAiVCA were higher than for IgAiMA (Fig. 2) . to VCA and EA of EBV is valuable for early diagnosis of NPC (Zeng et al., 1979; Zeng et al., 1980; Zeng et al., 1983a, b) . 58.3% of the NPC patients were found to have IgAiMA antibodies, whereas all normal individuals lacked IgA antibodies to this antigen. The situation is similar for IgAiEA antibodies (Zeng et al., 1983a) , suggesting that detection of the IgA/MA antibody could be used as a marker for the diagnosis of NPC.
However, the detection of EBV IgA/MA antibodies did not seem to be as sensitive for the diagnosis of NPC as IgANCA antibodies. Here we demonstrated that the rate of detection of IgA antibodies to EBV-MA by preabsorbing sera with SPA was drastically increased. Forsgren et al. (1966) first reported that SPA can bind to the FC sequence of IgG, but it is hardly effective in removing IgA from serum.
The limited concentration of antigen in the cells used for the fluorescence test is apparently competitively blocked by the usually high levels of IgGiMA. Thus, the removal of an excess of IgG yielded an enormous increase of sensitivity without increasing nonspecific reactions. This very sensitive test for detection of NPC is easy to perform, reproducible,
